CoChat

Antibody levels to recombinant VAR2CSA domains vary with Plasmodium falciparum parasitaemia, gestational age, and gravidity, but do not predict pregnancy outcomes

Open access

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index; 2 of the 7 sources its claims cite were checked for support.

Abstract

Study showing VAR2CSA antibody levels vary with parasitaemia, gestational age, and gravidity in pregnancy-associated malaria.

Overview

CoChat Summary

TL;DR

In a longitudinal cohort of pregnant women in Ouelessebougou, Mali, VAR2CSA antibody levels varied by gravidity, infection status, and gestational stage, with primigravidae showing short-lived boosts after malaria infection. However, these recombinant VAR2CSA domain antibody levels did not predict better pregnancy outcomes.

Key findings

  • Antibody levels to most VAR2CSA domains were higher in multigravidae than primigravidae at enrollment, gestational week 30–32, and delivery; GARP reactivity did not differ by gravidity.
  • Malaria infection increased VAR2CSA antibody levels, but the effect was gravidity-dependent: at enrollment, infected primigravidae had higher levels to all 11 domains, while infected secundigravidae and multigravidae had increases to 7 and 6 of 11 domains, respectively.
  • In women with no further infections, antibody levels in BS+ primigravidae declined sharply by delivery: 10/11 VAR2CSA domains were significantly lower at delivery, suggesting short-lived IgG; secundigravidae and multigravidae showed no significant decline.
  • Mean VAR2CSA antibody level was not associated with reduced risk of preterm delivery or pregnancy loss: HR 1.08 (95% CI 0.51–2.30) for preterm delivery and HR 1.13 (0.55–2.34) for pregnancy loss; similarly, no prediction was seen for LBW, SGA, maternal anaemia, birthweight, or gestational age.

Methods

  • Longitudinal cohort study of pregnant women (aged 15–45) in Ouelessebougou, Mali, enrolled Nov 2010–Oct 2013; plasma sampled at enrollment, gestational week 30–32, and delivery.
  • Antibodies to 11 recombinant VAR2CSA domains were measured by multiplex bead-based assay; analyses included singleton deliveries only.
  • Nonparametric group comparisons and multivariable regression/competing-risks models were used, adjusting for gravidity, malaria infection, IPTp, ITN use, and other covariates as specified.

Limitations

  • The paper explicitly notes a limitation of the pregnancy loss/preterm delivery analysis: relatively few cases of pregnancy loss and preterm delivery (6.8% and 7.8%, respectively).
  • Evident from the text: some women were not included at gestational week 30–32 because of miscarriage, stillbirth, preterm delivery, late enrollment, or missing shipped samples, which reduced sample size for that timepoint.
  • Evident from the text: the authors themselves suggest the recombinant VAR2CSA proteins may not present native protective epitopes, which limits interpretation of negative associations with outcomes.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s12936-018-2258-9

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Antibody levels to VAR2CSA domains stratified by gravidity. Levels at enrollment (a), gestational week 30–32 (b), and delivery (c) among primigravid (P, brown boxes), secundigravid (S, blue boxes) and multigravid (M, red boxes) women. Numbers that follow indicate the number of samples at enrollment, gestational week 30–32 and delivery in each gravid group: primigravidae (n = 157, 109, 152); secundigravidae (n = 118, 83, 114); multigravidae (n = 328, 245, 324). Significant differences between primigravidae and multigravidae are indicated with †, between primigravidae and secundigravidae with *, and between secundigravidae and multigravidae are indicated with §. The results are expressed as median fluorescent intensity (MFI). Box plot indicates the median (horizontal line) and interquartile range (box), the whiskers indicate the 10th and 90th percentiles
Fig. 1 Antibody levels to VAR2CSA domains stratified by gravidity. Levels at enrollment (a), gestational week 30–32 (b), and delivery (c) among primigravid (P, brown boxes), secundigravid (S, blue boxes) and multigravid (M, red boxes) women. Numbers that follow indicate the number of samples at enrollment, gestational week 30–32 and delivery in each gravid group: primigravidae (n = 157, 109, 152); secundigravidae (n = 118, 83, 114); multigravidae (n = 328, 245, 324). Significant differences between primigravidae and multigravidae are indicated with †, between primigravidae and secundigravidae with *, and between secundigravidae and multigravidae are indicated with §. The results are expressed as median fluorescent intensity (MFI). Box plot indicates the median (horizontal line) and interquartile range (box), the whiskers indicate the 10th and 90th percentilesCC BY · PubMed Central
Fig. 2 Antibody levels to VAR2CSA domains in malaria infected (grey boxes) and uninfected women (open boxes) at enrollment in primigravid (a, d), secundigravid (b, e) and multigravid (c, f) women. Infections detected by blood smear microscopy are shown in a–c, and submicroscopic infections detected by PCR in d–f. Numbers that follow indicate the number of samples with positive blood smear or positive by PCR and with no infection in each gravid group: primigravidae (a n = 63, 94; d n = 18, 73); secundigravidae (b n = 29, 89; e n = 19, 62); multigravidae (c n = 50, 278; f n = 65, 190). Significant differences in antibody levels in malaria-infected women versus uninfected indicated by an asterisk. The results are expressed as median fluorescent intensity (MFI). Box plot indicates the median (horizontal line) and interquartile range (box), the whiskers indicate the 10th and 90th percentiles
Fig. 2 Antibody levels to VAR2CSA domains in malaria infected (grey boxes) and uninfected women (open boxes) at enrollment in primigravid (a, d), secundigravid (b, e) and multigravid (c, f) women. Infections detected by blood smear microscopy are shown in a–c, and submicroscopic infections detected by PCR in d–f. Numbers that follow indicate the number of samples with positive blood smear or positive by PCR and with no infection in each gravid group: primigravidae (a n = 63, 94; d n = 18, 73); secundigravidae (b n = 29, 89; e n = 19, 62); multigravidae (c n = 50, 278; f n = 65, 190). Significant differences in antibody levels in malaria-infected women versus uninfected indicated by an asterisk. The results are expressed as median fluorescent intensity (MFI). Box plot indicates the median (horizontal line) and interquartile range (box), the whiskers indicate the 10th and 90th percentilesCC BY · PubMed Central
Fig. 3 Antibody levels to VAR2CSA domains expressed as mean antibody levels to 11 domains at enrollment (E, light shade) and at delivery (D, dark shade) in women with no infections during the study and women infected at enrollment only. Numbers that follow indicate the number of samples with no infection or infection at enrollment only at enrollment (E) and at delivery (D) in each gravid group: primigravidae (E, n = 66, 48; D, n = 64, 46); secundigravidae (E, n = 64, 22; D, n = 57, 23); multigravidae (E, n = 212, 38; D, n = 204, 40). Box plot indicates the median (horizontal line) and interquartile range (box), the whiskers indicate the 10th and 90th percentiles
Fig. 3 Antibody levels to VAR2CSA domains expressed as mean antibody levels to 11 domains at enrollment (E, light shade) and at delivery (D, dark shade) in women with no infections during the study and women infected at enrollment only. Numbers that follow indicate the number of samples with no infection or infection at enrollment only at enrollment (E) and at delivery (D) in each gravid group: primigravidae (E, n = 66, 48; D, n = 64, 46); secundigravidae (E, n = 64, 22; D, n = 57, 23); multigravidae (E, n = 212, 38; D, n = 204, 40). Box plot indicates the median (horizontal line) and interquartile range (box), the whiskers indicate the 10th and 90th percentilesCC BY · PubMed Central

Verification

Claims the paper makes

1 Valid · 0 Not valid · 4 Not checked · 41 Own results and interpretations

14 more claims

Create a free account to see all 46 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 6
  • It may state two separate claims as one. 24

Create a free account to see these claims.

Citations

Cites

Show all 36 references

Cited by

See all 30

Metadata

Authors
Fried, M., Kurtis, J. D., Swihart, B., Morrison, R., Pond-Tor, S., Barry, A., Sidibe, Y., Keita, S., Mahamar, A., Andemel, N., Attaher, O., Dembele, A. B., Cisse, K. B., Diarra, B. S., Kanoute, M. B., Narum, D. L., Dicko, A., & Duffy, P. E.
Affiliations
  • National Institutes of Health (US)
  • Brown University (US)
  • Université des Sciences, des Techniques et des Technologies de Bamako (ML)
Corresponding author
Fried, Michal
Venue
Malaria Journal
Published
2018-03-09
Volume
17
Issue
1
Pages
106-106
ISSN
1475-2875 (ISSN-L)
OpenAlex
W2794369759
Cited by
30
References
36
Citations by year
2026: 2 · 2025: 3 · 2024: 3 · 2023: 4 · 2022: 3 · 2021: 5 · 2020: 4 · 2019: 6
FWCI
3.57
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/4.0/ (tdm)
Locations
  • Malaria Journal (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Intramural Research Program of the NIAID-NIH
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
  • Health Sciences › Medicine › Hematology › Blood groups and transfusion
  • Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
Keywords
VAR2CSA, Plasmodium falciparum, maternal malaria, pregnancy outcomes, gravidity, primigravida, parasitemia, antibody levels, vaccine candidate, epitope specificity, placental malaria
MeSH terms
Adolescent, Adult, Antibodies, Protozoan, Antigens, Protozoan, Female, Gestational Age, Humans, Infant, Newborn, Longitudinal Studies, Mali, Middle Aged, Pregnancy, Pregnancy Complications, Infectious, Pregnancy Outcome, Malaria, Falciparum, Parasitemia, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antibody levels to recombinant VAR2CSA domains vary with Plasmodium falciparum parasitaemia, gestational age, and gravidity, but do not predict pregnancy outcomes. https://app.cochat.ai/papers/10.1186/s12936-018-2258-9
The paper
Fried, M., Kurtis, J. D., Swihart, B., Morrison, R., Pond-Tor, S., Barry, A., Sidibe, Y., Keita, S., Mahamar, A., Andemel, N., Attaher, O., Dembele, A. B., Cisse, K. B., Diarra, B. S., Kanoute, M. B., Narum, D. L., Dicko, A., & Duffy, P. E. (2018). Antibody levels to recombinant VAR2CSA domains vary with Plasmodium falciparum parasitaemia, gestational age, and gravidity, but do not predict pregnancy outcomes. Malaria Journal. https://doi.org/10.1186/s12936-018-2258-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.